The inhibitory effect of neutrophil chemotaxis of gentamicin, tobramycin, and sisomicin was shown. The combined effect of aminoglycosides and histamine was not additive. We have evaluated and compared the effect on neutrophil chemotaxis of three AGA of the gentamicin family, i.e., gentamicin, tobramycin, and sisomicin, to see whether the level oftoxicity is the same found in the case of metabolic activation and candidacidal activity.
The differential toxicity of various aminoglycoside antibiotics (AGA) for neutrophil functions, such as phagocytosis-dependent metabolic activation (1) and candidacidal activity (2) , has been reported and considered as a possible cause of the variable efficacy of the therapy with different AGA. The hypothesis is that AGA might cause a moderate impairment of neutrophil function that becomes relevant in neutropenic patients.
The effect of AGA on another function of neutrophils, i.e., chemotaxis, has been investigated by several authors, although with contrasting results; Forsgren and Schmeling (3) found no inhibitory effect; Khan et We have evaluated and compared the effect on neutrophil chemotaxis of three AGA of the gentamicin family, i.e., gentamicin, tobramycin, and sisomicin, to see whether the level oftoxicity is the same found in the case of metabolic activation and candidacidal activity.
Neutrophils were incubated (30 min at 3700) with a range of AGA concentrations and then tested in chemotaxis assays. In one set of three experiments, the cells were transferred directly from the incubation mixture to the upper Boyden chamber, in another set of three experiments, the cells were spin-washed before the chemotaxis assay.
In all cases both random and directed motilities were measured (9, 10) . No significant alteration of the random motility was ever found. The three AGA inhibited neutrophil chemotaxis in a dose-dependent manner. Dose-effect regressions are shown in Fig. 1 . The effects are clearly irreversible since the continuous presence of AGA in the assay seems to be irrelevant. Although 50% inhibition was reached at doses (17, 27, and 33 ,ug/ml for sisomycin, tobramycin, and gentamicin, respectively) which exceed the hematic levels used in therapy, the three curves extrapolate to values which are within those levels. To evaluate whether the AGA inhibitory effect on neutrophil chemotaxis could become even more pronounced on otherwise compromised neutrophils, we tested the combined effects of AGA and histamine, a known physiological inhibitor of chemotaxis (4). The inhibitory effect of 50% inhibitory concentration doses of each AGA was shown to be unchanged by the presence of a 50% inhibitory concentration dose of histamine ( Although it is not clearly established whether protein synthesis is necessary for metabolic activation, it is known that it is required for motility (7).
It is interesting to observe that the various AGA show differential toxicity upon different polymorphonuclear functions; metabolic activation and microbicidal activity are inhibited by gentamicin, tobramycin, and sisomicin in decreasing order of severity (1) 
